Change in Solys BioDyne Management
At the beginning of September, Stephan Goldenbaum became the new CEO of Estonian Solis BioDyne OÜ. CEO Priit Karjus stepped down to continue the Supervisory Board.
Goldenbaum has worked in biotech since 2003, beginning with Qiagen. From 2018 until joining Solis BioDyne, he worked on developing sales channels in the large Germany-based biotech company Eppendorf Group. He holds Masters degrees in biology and business integration
Solis BioDyne is operating in Tartu Science Park. The company was established in 1995 and develops and produce enzymes stable at room temperature due to a specific genetic modification – Stability TAG.